Company: ADZCF
Filing Date: 2025-08-04
Form Type: 424B2
Source: 0000950103-25-009784
Chunk: 16

Company: DEUTSCHE BANK AKTIENGESELLSCHAFT
Filing Date: 2025-08-04
Form: 424B2
Chunk 16
---
 will result in the return of any of your 
 investment.                                                                                                                            |

Risks Relating to Conflicts of Interest

| · | Trading and Other Transactions by Us, UBS or                                                                                                       
 Our or Its Affiliates in the Equity and Equity Derivative Markets May Impair the Value of the Notes — We                                           
 or our affiliates expect to hedge our exposure from the Notes by entering into equity and equity derivative transactions, such as over-the-counter 
 options, futures or exchange-traded instruments with one or more hedge counterparties, which will include UBS or its affiliates. We,               
 UBS or our or its affiliates may also engage in trading in instruments linked or related to the Underlying on a regular basis as part              
 of our or their general broker-dealer and other businesses, for proprietary accounts, for other accounts under management or to facilitate         
 transactions for customers, including block transactions. Such trading and hedging activities may adversely affect the value of the Underlying     
 and, therefore, make it less likely that you will receive a positive return on your investment in the Notes. It is possible that we, UBS           
 or our or its affiliates could receive substantial returns from these hedging and trading activities while the value of the Notes declines.        
 We, UBS or our or its affiliates may also issue or underwrite other securities or financial                                                        
 or derivative instruments with returns linked or related to the Underlying. To the extent that we, UBS or our or its affiliates serve              
 as issuer, agent or underwriter for such securities or financial or derivative instruments, our, UBS’ or our or its affiliates’                    
 interests with respect to such products may be adverse to those of the holders of the Notes. Introducing competing products into the marketplace   
 in this manner could adversely affect the value of the Underlying and the value of the Notes. Any of the foregoing activities described            
 in this paragraph may reflect trading strategies that differ from, or are in direct opposition to, investors’ trading and investment               
 strategies related to the Notes. Furthermore, because DBSI, UBS or one of its affiliates is expected to conduct trading and hedging activities     
 for us in connection with the Notes, DBSI, UBS or such affiliates may profit in connection with such trading and hedging activities and            
 such profit, if any, will be in addition to any compensation that DBSI or UBS receives for the sale of the Notes to you. You should be             
 aware that the potential to earn a profit in connection with hedging activities